Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Ginkgo Bioworks and Novo Nordisk to Collaborate on Expression Systems for Pharmaceutical Products
Wednesday, June 08, 2022Ginkgo Bioworks the leading horizontal platform for cell programming today announced a collaboration with Novo Nordisk a leading global healthcare company to create novel expression hosts for pharmaceutical products Today hundreds of millions of peop...
BioCryst Announces Approval of ORLADEYO® (berotralstat) by Swissmedic
Wednesday, June 08, 2022BioCryst Pharmaceuticals Inc announced that Swissmedic has granted marketing authorization for oral oncedaily ORLADEYO berotralstat for the routine prevention of recurrent hereditary angioedema HAE attacks in patients years and older in Switzerland...
Parse Biosciences Announces Partnership with Molecular Diagnostics Korea
Tuesday, June 07, 2022Parse Biosciences a leading provider of scalable singlecell sequencing solutions today announced a partnership with Molecular Diagnostics Korea MDxK that will expand its presence in Asia by providing its entire line of Evercode Whole Transcriptome pr...
Antengene Announces HREC Approval in Australia for the Phase I Trial of the Small Molecule ATR Inhibitor ATG-018
Tuesday, June 07, 2022Antengene Corporation Limited a leading commercialstage global biopharmaceutical company dedicated to discovering developing and commercializing firstinclass andor bestinclass therapeutics in hematology and oncology today announced that Antengene has...
Biogen and Samsung Bioepis’ BYOOVIZ™ (ranibizumab-nuna) Launches in the United States
Friday, June 03, 2022Biogen Inc and Samsung Bioepis Co Ltd today announced that BYOOVIZ ranibizumabnuna a biosimilar referencing LUCENTIS ranibizumabi has been launched in the United States Healthcare provider engagement promotional activity collaborations with professio...
Moderna and the European Commission Agree on Amendment to COVID-19 Vaccine Supply Agreement
Friday, June 03, 2022Moderna Inc a biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines today announced an agreement with the European Commission EC to amend their originally agreed contractual delivery schedules for the Moderna COVID vaccine boo...
Amneal Launches LYVISPAH® (baclofen) for Spasticity Related to Multiple Sclerosis and Other Spinal Cord Disorders
Thursday, June 02, 2022Amneal Pharmaceuticals Inc announced the commercial launch of LYVISPAH a baclofen oral granules and mg specialty product approved by the US Food and Drug Administration FDA for the treatment of spasticity related to multiple sclerosis and other sp...
Cambrex Acquires Leading EU Stability Storage Company Q1 Scientific
Thursday, June 02, 2022Cambrex a leading global contract development and manufacturing organization CDMO providing drug substance drug product and analytical services across the entire drug lifecycle today announced the acquisition of Q Scientific a leading provider of en...
Bone Therapeutics signs definitive subscription agreement for a maximum of EUR 5M convertible bonds facility with ABO
Wednesday, June 01, 2022Bone Therapeutics the cell therapy company addressing unmet medical needs in orthopedics today announces that it has signed the definitive subscription agreement for a maximum EUR million convertible bonds CBs facility arranged by ABO Securities thr...
Astellas and GO Therapeutics Enter into Strategic Research and License Agreement to Develop Novel Antibodies for Immuno-Oncology
Wednesday, June 01, 2022Astellas Pharma Inc and GO Therapeutics Inc announced that Xyphos Biosciences Inc a wholly owned subsidiary of Astellas Xyphos and GO have entered into a strategic research collaboration and license agreement to develop novel ImmunoOncology therapeut...
